ProCE Banner Activity

CCO Highlights of 2024 Hematology Meetings: Focus on Rare Blood Diseases

Slideset

Downloadable slideset with essential clinical trial data updates for nonmalignant rare blood diseases that were presented at various hematology conferences in 2024.

Released: August 21, 2024

Expiration: August 20, 2025

Share

Faculty

Ghose Ken

Ghose Ken, MD

John Mascarenhas

John Mascarenhas, MD

Director
Center of Excellence in Blood Cancers and Myeloid Disorders
Director
Adult Leukemia Program
Leader
Myeloproliferative Disorders Clinical Research Program
Division of Hematology/Oncology
Tisch Cancer Institute
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, New York

Timothy Scialla

Timothy Scialla, MD

Associate Professor
Division of Pulmonary, Allergy, and Critical Care Medicine
Department of Medicine
University of Virginia School of Medicine
Charlottesville, Virginia

Guy Young

Guy Young, MD

Director, Hemostasis and Thrombosis Center
Director, Clinical Coagulation Laboratory
Cancer and Blood Disorders Institute
Children’s Hospital Los Angeles
Professor of Pediatrics
Division of Hematology/Oncology
Department of Pediatrics
University of Southern California Keck School of Medicine
Los Angeles, California

PT Faculty

Timothy Scialla

Timothy Scialla, MD

Associate Professor
Division of Pulmonary, Allergy, and Critical Care Medicine
Department of Medicine
University of Virginia School of Medicine
Charlottesville, Virginia

Chetasi Talati

Chetasi Talati, MD

Assistant Professor
Department of Oncologic Sciences
Assistant Member
Malignant Hematology
Moffitt Cancer Center
University of South Florida
Tampa, Florida

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Novo Nordisk.

Novo Nordisk